register

ESG

Osteoporosis Australia welcomes $4M for National Action Plan to enhance quality of care

Health Industry Hub | October 18, 2019 |

Osteoporosis Australia (OA), and the Australian Government officially launched the National Strategic Action Plan for Osteoporosis in Canberra on Thursday 17 October 2019, with the Minister for Health, The Hon. Greg Hunt MP, in the lead up to World Osteoporosis Day (Sunday, October 20, 2019).

The National Strategic Action Plan for Osteoporosis will provide critical support to the 4.7 million Australians aged over 50 who currently live with poor bone health, and embark on a preventative approach to reduce future bone fractures and the impact of osteoporosis on the Australian healthcare system.

In 2019, the cost of osteoporosis will reach over $2.1 billion – 70 per cent of which will be directly related to fracture costs. Australians will sustain up to 165,000 broken bones (fractures) due to poor bone health, with 4.7 million Australians over 50 continuing to be impacted by the disease.

The Hon. Greg Hunt MP, Minister for Health, stated the launch of the National Strategic Action Plan for Osteoporosis is a significant step in improving the quality of life for Australians living with poor bone health, and reducing the substantial financial burden that osteoporosis has on the Australian healthcare system.

“The Action Plan addresses the urgent need for a national strategic response to the challenges and burden of osteoporosis across Australia. It will focus on increased awareness, education and prevention of osteoporosis, including improved diagnosis and management, and care of people with, or at risk of, osteoporosis.

“The Government is allocating $4 million to support implementation of the Action Plan,” said Minister Hunt.

Currently 66 per cent of Australians aged over 50 are estimated to have poor bone health. Hip fractures remain the costliest type of fracture related to osteoporosis. Other types of fractures remain widespread – wrist, spinal, arm and leg fractures. While osteoporosis mainly affects women, men also need to check their bone health, with 25 per cent of cases occurring in men.

Senator The Hon. Richard Colbeck, Minister for Aged Care and Senior Australians, said the National Strategic Action Plan will have a substantial impact on the management and prevention of osteoporosis.

“Millions of Australians are affected by osteoporosis and poor bone health. The Morrison Government’s $4 million investment in the National Strategic Action Plan for Osteoporosis will support better prevention of osteoporosis and poor bone health, and will help improve quality of life for people across Australia, particularly seniors,” Minister Colbeck said.

OA CEO, Mr Greg Lyubomirsky, welcomed the launch of the Action Plan, stating the Plan sets out important priorities and actions to guide efforts to prevent poor bone heath and ensure osteoporosis is a national priority.

“This is an exciting outcome for osteoporosis prevention, as this is the first time osteoporosis has received the attention it deserves. OA commends Minister Hunt and Minister Colbeck on their commitment to making this substantial investment to commence implementation of key actions in the Plan. This is an important step forward in supporting the 4.7 million Australians with poor bone health,” said Mr Lyubomirsky.

The evidence-based plan provides a roadmap to improve the prevention, diagnosis and management of osteoporosis nationally. The plan aims to reduce the personal and economic burden that osteoporosis and related fractures have on the community, and in particular, on older Australians.

For more information, visit www.osteoporosis.org.au

You may also like First mental illness to be assigned MBS diagnostic category


News & Trends - Pharmaceuticals

Federal court dismisses Arrotex dispute against Health Minister

Federal court dismisses Arrotex dispute against Health Minister

Health Industry Hub | July 12, 2024 |

Pharma News: The Federal Court has ruled against Arrotex Pharmaceuticals in their bid to challenge the Minister for Health and […]

More


News & Trends - Pharmaceuticals

Largest diabetes study reveals major benefits of dual therapy with SGLT2 inhibitors and GLP1 receptor agonists

Largest diabetes study reveals major benefits of SGLT2 inhibitors and GLP1 receptor agonists dual therapy

Health Industry Hub | July 12, 2024 |

Pharma News: Combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to […]

More


News & Trends - Pharmaceuticals

Queensland opens first regional CAR T-cell treatment centre

Queensland launches first regional CAR T-cell treatment centre

Health Industry Hub | July 12, 2024 |

Pharma News: Gilead Sciences and Lymphoma Australia have welcomed the opening of Australia’s first regional CAR T-cell treatment centre at […]

More


News & Trends - Pharmaceuticals

Government inaction leaves essential medicine shortages unresolved

Government inaction leaves essential medicine shortages unresolved

Health Industry Hub | July 12, 2024 |

Pharma News: Over the past 12 months, at least six essential medications and products have been withdrawn from the Australian […]

More


This content is copyright protected. Please subscribe to gain access.